JPRN-UMIN000002685
Completed
未知
Feasibility study of outpatient chemotherapy with S-1+CDDP in gastric cancer patients - Feasibility study of outpatient chemotherapy with S-1+CDDP in gastric cancer patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Cancer Center Hospital
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) History of hypersensitivity to S\-1 or CDDP. 2\) Receiving fluoropyrimidine preparation. 3\) Receiving systemic steroid therapy. 4\) Required to continue to take flucytosine, phenytoin, and warfarin. 5\) Severe complications (ileus, bowel obstruction, interstitial lung disease, uncontrolled diabetes, severe arrhythmia, heart failure, renal failure, liver cirrhosis, active hepatitis, and so on). 6\) Active ischemic heart disease. 7\) Woman who are pregnant, lactating, or willing to get pregnant, or man who are willing to have unprotected intercourse. 8\) Severe mental disorder. 9\) Regarded as inadequate physical conditions by attending physician.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Feasibility study of outpatient chemotherapy with Capecitabine plus fractional Cisplatin for Advanced or Recurrent Gastric CancerPatients with unresctable or recurrent gastric cancerJPRN-UMIN000006385ihon Medical School Musasikosugi Hospital12
Recruiting
Not Applicable
Feasibility study of perioperative chemotherapy with neoadjuvant GEM+CDDP and adjuvant S-1 for biliary tract cancerBiliary tract cancerJPRN-UMIN000021206Keio University School of Medicine30
Completed
Not Applicable
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
Completed
Phase 2
Feasibility trial of neoadjuvant chemotherapy with docetaxel,cisplatin and fluorouracil for clinical stage II/III esophageal carcinoma.esophageal neoplasmJPRN-UMIN000002396Saitama Cancer Center40
Recruiting
Not Applicable
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20